News & Events
Category: Press Releases 10 November 2020
Marking a milestone for gene editing
We are pleased to share that Richmond Pharmacology, in partnership with Intellia Therapeutics and the Royal Free Hospital, have treated the first patient in a landmark CRISPR/Cas9 clinical trial of NTLA-2001.
Category: Events 2 September 2020
From Target to Market
The GLA Biotech & Pharma Summer School
Michael Hildebrand, Wolf-Stefan Richter und Jens Hoffmann will present at "From Target to Market – The GLA Biotech & Pharma Summer School" from 2nd to 5th of September in Berlin.
Category: Events 26 May 2020
Virtual EAN 2020
Christian Wolf will attend the virtual 6th Congress of the European Academy of Neurology from 23-26 May 2020.
Program: https://www.ean.org/congress-2020
Category: Events 22 May 2020
Digital business development event – Partnering for life sciences
Aurexel is about to participate to the Biotechgate digital partnering event on May 18-20
Category: Events 20 May 2020
Cardiac Safety Conference
Date: May 20th, Wednesday
Location: online event
In celebration of the World Clinical Trials Day, the RRI and RPL are proud to host a Cardiac Safety Conference to discuss emerging drug development programmes. The event will discuss new insights into improved patient outcomes, efficiency and cost effectiveness of global drug development.
Category: COVID-19 8 April 2020
Management of pulmonary Imaging in clinical research during the COVID-19 crisis
Trialists, researchers, investigators and sponsors: you will need to manage all those lung images in all emerging COVID-19 research and in many ongoing clinical trials. Pharmtrace, a member of Conelis e.V. offers a GCP and privacy-compliant online image management platform which is ready to go. For all academic networks fighting the COVID-19 pandemia, the service will be offered for free.
http://pharmtrace.com/en/image-management/pharmtrace-supports-covid-19-research/
Category: COVID-19 7 April 2020
Digital tools may support during the COVID-19 crisis
Staying informed about digital innovation in times of COVID-19? Subscribe to the newsletter on corona-digital.de, a website of the German health innovation hub (hih) – rapidly put in place by CONELIS member Christian Nagelstrasser and his company INDEGO (www.indego.net/)
Category: COVID-19 23 March 2020
Accelero received needed permits for processing SARS-CoV-2 in biological samples and works on antibody detection
Accelero Bioanalytics GmbH has received the authority permit for processing and analysis of SARS-CoV-2 in biological samples. The Berlin State Office for Occupational Safety, Health Protection, and Technical Safety (LAGetSi) as well as the local Health Department in Treptow-Köpenick both allowed the processing and analysis of upper and lower respiratory specimen (swaps, sputum, bronchoalveolar lavage) via SARS-CoV-2 specific RTqPCR assays.
Category: COVID-19 23 March 2020
COVID-19 and Risk Management in a Phase I unit
CONELIS e.V. is sharing this post of our member Jörg Täubel, CEO of Richmond Pharmacology that highlights a well thought through approach to conducting clinical research in times of COVID-19. Jörg shows us what good management and care can look like – with clear responsibilities, caring about patients, volunteers, and staff. A good example of proper risk management.
Category: Press Releases 27 February 2020
Richmond Research Institute launches to empower improved safety and discovery of medicines
Richmond Pharmacology Ltd has officially launched its dedicated not-for-profit research institute to bring together academic institutions and scientific experts with a mission to advance the safety and discovery of medicinal products.